Vera Therapeutics Inc. (VERA)
NASDAQ: VERA
· Real-Time Price · USD
24.76
0.52 (2.15%)
At close: Sep 16, 2025, 3:59 PM
24.80
0.16%
After-hours: Sep 16, 2025, 06:59 PM EDT
2.15% (1D)
| Bid | 24.11 |
| Market Cap | 1.58B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -218.28M |
| EPS (ttm) | -3.59 |
| PE Ratio (ttm) | -6.9 |
| Forward PE | -5.28 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 25 |
| Volume | 1,286,574 |
| Avg. Volume (20D) | 1,852,726.5 |
| Open | 24.33 |
| Previous Close | 24.24 |
| Day's Range | 24.19 - 24.92 |
| 52-Week Range | 18.53 - 51.61 |
| Beta | 1.16 |
| Ex-Dividend Date | n/a |
About VERA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VERA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VERA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+67.49%
Vera Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
8 months ago
-6.08%
Vera Therapeutics shares are trading lower. The company announced an exclusive license agreement with Stanford University for VT-109.
